CD40 and B Chronic Lymphocytic Leukemia Cell Response To Fludarabine: The Influence of NF-kB/Rel Transcription Factors On Chemotherapy-Induced Apoptosis

References

• Fisher D. E. Apoptosis in cancer therapy: crossing the threshold. Cell 1994; 89: 539–42
   Web of Science ®Google Scholar
• Baldini N. Multidrug resistance - a multiplex phenomenon. Nat Med 1997; 3: 378–80
   PubMed Web of Science ®Google Scholar
• Banchereau J., Bazan R., Blanchard D., Briére R., Galizzi J. R., van Kooten C., Liu Y. J., Rousset R., Saekand S. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12: 881–922
   PubMed Web of Science ®Google Scholar
• Smith C. A., Farrah T., Goodwin R. G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994; 76: 959–62
   PubMed Web of Science ®Google Scholar
• Lane P., Traunecker A., Hubele S., Inui S., Lanzavecchia A., Gray D. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell- dependent activation of B lymphocytes. Eur J Immunol 1992; 22: 2573–8
   PubMed Web of Science ®Google Scholar
• Roy M., Waldschmidt T., Aruffo A., Ledbetter J. A., Noelle R. J. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J Immunol 1993; 151: 2497–510
   PubMed Web of Science ®Google Scholar
• Foy M. T., Aruffo A., Bajorath J., Buhlmann J. E., Noelle R. J. Immune regulation by CD40 and its ligand gp39. Annu Rev Immunol 1996; 14: 591–617
   PubMed Web of Science ®Google Scholar
• Liu Y. J., Johnson G. D., Gordon J., MacLennan I. C. Germinal centres in T-cell-dependent antibody responses. Immunol Today 1992; 13: 17–21
   PubMedGoogle Scholar
• Durie F. H., Foy T. M., Masters S. R., Laman J. D., Noelle R. J. The role of CD40 in the regulation of humoral and cell- mediated immunity. Immunol Today 1994; 15: 406–11
   PubMedGoogle Scholar
• Choi M. S., Boise L. H., Gottschalk A. R., Quintas J., Thompson C. B., Klaus G. G. Eur J Immunol 1995; 25: 1352–7
   PubMed Web of Science ®Google Scholar
• Baker M. P., Eliopoulos A. G., Young L. S., Armitage R. J., Gregory C. D., Gordon J. Prolonged phenotypic, functional, and molecular change in group I Burkitt lymphoma cells on short- term exposure to CD40 ligand. Blood 1998; 92: 2830–43
   PubMed Web of Science ®Google Scholar
• Schattner E. J., Elkon K. B., Yoo D. H., Tumang J., Krammer P. H., Crow M. K., Friedman S. M. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 1995; 182: 1557–65
   PubMed Web of Science ®Google Scholar
• Funakoshi S., Longo D. L., Beckwith M., Conley D. K., Tsarfaty I., Armitage R. J., Fanslow W. C., Spriggs M. K., Murphy W. J. Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood 1995; 83: 2787–94
   Web of Science ®Google Scholar
• Dilloo D., Brown M., Roskrow M., Zhong W., Holladay M., Holden W., Brenner M. CD40 ligand induces an antileukemia immune response in vivo. Blood 1997; 92: 1927–33
   Google Scholar
• Kato K., Cantwell M. J., Sharma S., Kipps T. J. Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells. J Clin Invest 1998; 101: 1133–41
   PubMed Web of Science ®Google Scholar
• Romano M. F., Lamberti A., Tassone P., Alfinito F., Costantini S., Chiurazzi F., Defrance T., Bonelli P., Tuccillo M. F., Turco M. C., Venuta S. Triggering of CD40 antigen inhibits fludarabine- induced apoptosis in B chronic lymphocytic leukemia cells. Blood 1998; 92: 990–5
   PubMed Web of Science ®Google Scholar
• Voorzanger-Rousselot N., Favrot M., Blay J. Y. Resistance to cytotoxic chemotherapy induced by CD40 ligand in lymphoma cells. Blood 1998; 92: 3381–7
   PubMed Web of Science ®Google Scholar
• Walker A., Taylor S. T., Hickman J. A., Dive C. Germinal center derived signals act with bcl-2 to decrease apoptosis and increase clonogenicity of drug treated human B lymphoma cells. Cancer Res 1997; 57: 1939–46
   PubMed Web of Science ®Google Scholar
• Younes A., Snell V., Consoli U., Clodi K., Zhao S., Palmer J. L., Thomas E. K., Armitage R. J., Andreeff M. Elevated levels of biologically active soluble CD40 ligand in the serum of patients with chronic lymphocytic leukemia. Br J Haematol 1998; 100: 135–41
   PubMed Web of Science ®Google Scholar
• Trentin L., Zambello R., Sancetta R., Facco M., Cerutti A., Perin A., Siviero M., Basso U., Bortolin M., Adami F., Agostini C., Semenzato G. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules. Cancer Res 1997; 57: 4940–7
   PubMed Web of Science ®Google Scholar
• Schattner E. J., Mascarenhas J., Reyfman I., Koshy M., Woo C., Friedman S. M., Crow M. K. Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity. Blood 1998; 91: 2689–97
   PubMed Web of Science ®Google Scholar
• Vinante E., Rigo A., Tecchio C., Morosato L., Nadali G., Ricetti M. M., Krampera M., Zanolin E., Locatelli F., Gallati H., Chilosi M., Pizzolo G. Serum levels of p55 and p75 soluble TNF receptors in adult acute leukemia at diagnosis: correlation with clinical and biological features and outcome. Br J Haematol 1998; 102: 1025–34
   PubMed Web of Science ®Google Scholar
• Barak V., Nisman B., Polliack A. The tumor necrosis factor family and correlation with disease activity and response to treatment in hairy cell leukemia. Eur J Haematol 1999; 62: 71–75
   PubMed Web of Science ®Google Scholar
• Beg A. A., Baltimore D. An essential role of NF-B in preventing TNF-α- induced cell death. Science 1996; 274: 782–4
   PubMed Web of Science ®Google Scholar
• Liu Z-G., Hsu H., Goeddel D. V., Garin M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-B activation prevents cell death. Cell 1996; 87: 565–71
   PubMed Web of Science ®Google Scholar
• Van Antwerp D. J., Martin S. J., Kafri T., Green D. R., Verma I. M. Suppression of TNF-α- induced apoptosis by NF-B. Science 1996; 274: 787–9
   PubMed Web of Science ®Google Scholar
• Wang C-Y., Mayo M. W., Baldwin A. S. TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NF-B. Science 1996; 274: 784–7
   PubMed Web of Science ®Google Scholar
• Wu M., Lee H., Bellas R. E., Schauer S. L., Arsura M., Katz D., Fitz Gerald M. J., Rothstein Y. L., Sherr D. H., Sonenshein G. E. Inhibition of NF-B/Rel induces apoptosis of murine B cells. EMBO J. 1996; 15: 4682–7
   PubMed Web of Science ®Google Scholar
• Van Antwerp D. J., Martin S. J., Verma I. M., Green D. R. Inhibition of TNF- induced apoptosis by NF-B. Trends Cell Biol 1998; 8: 107–11
   PubMed Web of Science ®Google Scholar
• Bauerle P. A., Baltimore D. NF-B: ten years after. Cell 1996; 87: 13–6
   PubMed Web of Science ®Google Scholar
• Baldwin A. S., Jr. The NF-B and IB proteins: new discoveries and insights. Annu Rev Immunol 1996; 14: 649–83
   PubMed Web of Science ®Google Scholar
• Ghosh S., May M. J., Kopp E. B. NF-B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225–60
   PubMed Web of Science ®Google Scholar
• Zong W. X., Bash J., Gelinas C. Rel blocks both anti-Fas- and TNFα-induced apoptosis and an intact Rel transactivation domain is essential for this effect. Cell Death Differ 1998; 5: 963–72
   PubMed Web of Science ®Google Scholar
• Wang C. Y., Cusack J. C., Jr., Liu R., Baldwin A. S., Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-B. Nat Med 1999; 5: 412–7
   PubMed Web of Science ®Google Scholar
• Chu Z. L., McKinsey T. A., Liu L., Gentry J. J., Malim M. H., Ballard D. W. Suppression of tumor necrosis factor- induced cell death by inhibitor of apoptosis c-IAP2 is under NF-B control. Proc Natl Acad Sci USA 1997; 94: 10057–62
   PubMed Web of Science ®Google Scholar
• Wang C. Y., Mayo M. W., Korneluk R. G., Goeddel D. V., Baldwin A. S., Jr. NF-B antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation. Science 1998; 281: 1680–3
   PubMed Web of Science ®Google Scholar
• Wu M. X., Ao Z., Prasad K. V.S., Wu R., Schlossman S. F. IEX-1L, an apoposis inhibitor involved in NF-B- mediated cell survival. Science 1998; 281: 998–1001
   PubMed Web of Science ®Google Scholar
• Grumont R. J., Rourke I. J., Gerondakis S. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation- induced apoptosis. Genes Dev 1999; 13: 400–11
   PubMed Web of Science ®Google Scholar
• Zong W. X., Edelstein L. C., Chen C., Bash J., Gelinas C. The prosurvival Bcl-2 homolog Bfl-l/A1 is a direct transcriptional target of NF-B that blocks TNFα-induced apoptosis. Genes Dev 1999; 13: 382–7
   PubMed Web of Science ®Google Scholar
• Opipari A. W., Jr., Hu H. M., Yabkowitz R., Dixit V. M. The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 1992; 267: 12424–9
   PubMed Web of Science ®Google Scholar
• Dimmeler S., Haendeler J., Sause A., Zeiher A. M. Nitric oxide inhibits APO-1/Fas- mediated cell death. Cell Growth Differ 1998; 9: 415–9
   PubMedGoogle Scholar
• Berberich I., Shu G. L., Clark E. A. Cross- linking CD40 on B cells rapidly activates NF-B. J Immunol 1994; 153: 4357–66
   PubMed Web of Science ®Google Scholar
• Rothe M., Sarma V., Dixit V. M., Goeddel D. V. TRAF2- mediated activation of NF-B by TNF receptor 2 and CD40. Science 1995; 269: 1424–7
   PubMed Web of Science ®Google Scholar
• Sutherland C. L., Krebs D. L., Gold M. R. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N- terminal Kinase, activation of MAPKAP kinase-2, phosphorylation of IBα, and protection of WEHI-231 cells from anti-IgM- induced growth arrest. J Immunol 1999; 162: 4720–30
   PubMed Web of Science ®Google Scholar
• Chen C. C., Rosenbloom C. L., Anderson D. C., Manning A. M. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of IBα phosphorylation. J Immunol 1995; 155: 3538–45
   PubMed Web of Science ®Google Scholar
• Morishita R., Sugimoto T., Aoki M., Kida I., Tomita N., Moriguchi A., Maeda K., Sawa Y., Kaneda Y., Higaki J., Ogihara T. In vivo transfection of cis element “decoy” against NF-B binding site prevents myocardial infarction. Nat Med 1997; 3: 894–9
   PubMed Web of Science ®Google Scholar
• Khaled A. R., Butfiloski E. J., Sobel E. S., Schiffenbauer J. Use of phosphorothioate- modified oligodeoxynucleotides to inhibit NF-B expression and lymphocyte function. Clin Immunol Immunopathol 1998; 86: 170–9
   PubMedGoogle Scholar
• Bishop M. R., Iversen P. L., Bayever E., Sharp J. G., Greiner T. C., Copple B. L., Ruddon R., Zon G., Spinolo J., Arneson M., Armitage J. O., Kessinger A. Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies. J Clin Oncol 1996; 14: 1320–6
   PubMed Web of Science ®Google Scholar
• Webb A., Cunningham D., Cotter F., Clarke P. A., di Stefano F., Ross P., Corbo M., Dziewanowska Z. BCL-2 antisense therapy in patients with non-Hodgkin lymphoma. Lancet 1997; 349: 1137–41
   PubMed Web of Science ®Google Scholar
• Chen F., Castranova V., Shi X., Demers L. M. New insights into the role of NF-B, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999; 45: 7–17
   PubMed Web of Science ®Google Scholar
• Waddick K. G., Uckun F. M. Innovative treatment programs against cancer: II. NF-B as a molecular target. Biochem Pharmacol 1999; 57: 9–17
   PubMed Web of Science ®Google Scholar
• Bentires-Alj M., Hellin A. C., Ameyar M., Chouaib S., Merville M. P., Bours V. Stable inhibition of NF-B in cancer cells does not increase sensitivity to cytotoxic drugs. Cancer Res 1999; 59: 811–5
   PubMed Web of Science ®Google Scholar
• Lin Z. P., Boiler Y. C., Amer S. M., Russell R. L., Pacelli K. A., Patiemo S. R., Kennedy K. A. Prevention of brefeldin A- induced resistance to teniposide by the proteasome inhibitor MG-132: involvement of NF-B activation in drug resistance. Cancer Res 1998; 58: 3059–65
   PubMed Web of Science ®Google Scholar